PPK Group Limited announced that the company has agreed to partner with Deakin, who will provide the research and development expertise, and industry partner Dr. David Dunn, a noted aesthetic dentist with more than 25 years clinical and diagnostic experience in cosmetic dentistry and dental implants. This will be the third industry vertical application that PPK and Deakin have entered into that will benefit from the use of innovative incorporation of BNNT into a traditional GLOBAL industry. Initial ownership of the venture vehicle, 3D Dental Technology Limited, will be PPK (45%), David Dunn (45%) and Deakin (10%) with funding provided by all three shareholders in proportion to their investment. Deakin will be contracted to provide research and development which will occur over the duration of the project. The 3D Dental Technology Project focuses on the development of new nanocomposites for a variety of dental materials including Zirconia, Lithium disilicate, Alumina and Composite resins based on the incorporation of BNNT in the molecular matrix of these materials. Although mechanically hard, current ceramic composite structures like veneers, crowns and bridges are considered to have an unacceptably high failure rate. BNNT provides incredible micro-tensile strength in ceramics while having no impact on colour, being non-toxic, not impacted by salivary flow or food acids and should remain stable in a nanocomposite indefinitely. These new nanocomposites represent innovative forms of materials for use in prosthetic and implant dentistry including inlays, onlays, veneers, crowns and a variety of both tooth and implant supported bridge constructions.